Sign up Australia
Proactive Investors - Run By Investors For Investors

No pressure as Pressure BioSciences admitted to Richmond Club Index

Pressure BioSciences Inc has been added to the prestigious Richmond Club Index, which has outperformed the S&P 500 Index by an average of 11% each year since its inception ten years ago, the company announced on Tuesday
The measure of a successful company
The measure of a successful company

Pressure BioSciences Inc (OTCMKTS:PBIO) has been added to the prestigious Richmond Club Index, which has outperformed the S&P 500 Index by an average of 11% each year since its inception ten years ago, the company announced on Tuesday.

The Richmond Club boasts roughly 550 members, comprised of a mix of investment advisors, fund managers, analysts, and members of the media.

Pressure BioSciences is a leader in the development and sale of broadly enabling pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry.

Inclusion in the Richmond Club Index is difficult to achieve.  To be invited, the Richmond Club initially screens thousands of publicly-traded companies, chooses a few to interview, then selects the best company among the finalists that it believes is the most undervalued relative to its peers, and also offers excellent growth potential.

"This new investor recognition, building upon PBI's recent growth momentum together with important financial, strategic marketing, and new product achievements, lead us to believe that 2016 will be our most successful year to date," said Richard T. Schumacher, President and CEO of PBI.

 

View full PBIO profile View Profile

Pressure BioSciences Inc Timeline

Related Articles

1528305384_Untitled-design-(3).jpg
June 07 2018
Ventripoint received key FDA approval to sell the device with the four-chamber heart analysis last month
Workers at CERN
August 02 2018
Private banks and healthcare groups took part in the share placing
1527682514_angel-delight.jpg
May 30 2018
The latest fundraiser underscores the fact the life sciences business is well supported in the City

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use